Former FDA Commissioner Scott Gottlieb Will Offer Insights at Upcoming Oncology Conferences

Jason Harris
Published: Friday, Oct 18, 2019
Scott Gottlieb, MD, former FDA Commissioner, Seattle Cancer Care Alliance

Scott Gottlieb, MD

When Scott Gottlieb, MD, stepped down from his post as FDA commissioner in April 2019, he had earned praise and respect for his willingness to take on important issues, such as opioid regulation1 and the marketing of tobacco products to youths2 (Timeline1-10).

He said the entire field of cancer care is being transformed through new technology. Not just new therapeutics, but new diagnostic tools are also profoundly changing the way doctors practice oncology.

Timeline. Highlights of Scott Gottlieb's Tenure at FDA

Timeline. Highlights of Scott Gottlieb's Tenure at FDA
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x